N@N

Andrew Fein Initiated (BIIB) at Strong Buy and Held Target at $380 on, Aug 11th, 2015

Andrew Fein of HC Wainwright & Co., Initiated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $380 on, Aug 11th, 2015.

Andrew has made no other calls on BIIB in the last 4 months.

There are 7 other peers that have a rating on BIIB. Out of the 7 peers that are also analyzing BIIB, 4 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Brian Skorney of "Baird" Downgraded from Buy to Hold and Decreased Target to $316 on, Monday, July 27th, 2015
• Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $410 on, Wednesday, July 22nd, 2015
• Jay Olson of "Oppenheimer" Initiated at Hold on, Monday, April 27th, 2015
• Christopher Marai of "Nomura" Maintained at Hold with Increased Target to $442 on, Monday, April 27th, 2015

These are the ratings of the 3 analyists that currently disagree with Andrew

---

• Aaron Gal of "Bernstein" Upgraded from Hold to Buy and Decreased Target to $385 on, Monday, July 27th, 2015
• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $426 on, Monday, July 27th, 2015
• Geoffrey Porges of "Leerink Swann" Maintained at Buy with Decreased Target to $512 on, Thursday, June 11th, 2015

Contributing Sources

---